Fangman Chen

Fangman Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Science Advances
Verified
Journal Article
Open access
CSChengxin Shi
Chengxin Shi
JDJianati Dawulieti
Jianati Dawulieti
FSFeiyu Shi
Feiyu Shi
CYChao Yang
Chao Yang
QQQian Qin
Qian Qin
JSJunjun She
Junjun She
A therapeutic strategy that targets multiple proinflammatory factors in inflammatory bowel disease (IBD) with minimal systemic side effects would be attractive. Here, we develop a drug-free, biodegradable nanomedicine that acts against IBD by scavenging proinflammatory cell-free DNA (cfDNA) and reactive oxygen species (ROS). Polyethylenimine (PEI) was conjugated to antioxidative diselenide-bridged mesoporous organosilica nanoparticles (MONs) to formulate nanoparticles (MON-PEI) that exhibited high cfDNA binding affinity and ROS-responsive degradation. In ulcerative colitis and Crohn’s disease mouse colitis models, orally administered MON-PEI accumulated preferentially in the inflamed colon and attenuated colonic and peritoneal inflammation by alleviating cfDNA- and ROS-mediated inflammatory responses, allowing a reduced dose frequency and ameliorating colitis even after delayed treatment. This work suggests a new nanomedicine strategy for IBD treatment.

3 May 2023 in ACS Nano
Verified
Journal Article
Closed access
JLJia-Qi Luo
Jia-Qi Luo
RLRong Liu
Rong Liu
FCFang-Man Chen
Fang-Man Chen
JZJing-Yang Zhang
Jing-Yang Zhang
SZSui-Juan Zheng
Sui-Juan Zheng
JDJin-Zhi Du
Jin-Zhi Du

1 January 2022 in Theranostics
Verified
Journal Article
Open access
JPJiahui Peng
Jiahui Peng
FCFangman Chen
Fangman Chen
YLYulu Liu
Yulu Liu
FZFan Zhang
Fan Zhang
LCLei Cao
Lei Cao
WDWen-Fei Dong
Wen-Fei Dong
Designing a transformable nanosystem with improved tumor accumulation and penetration by tuning multiple physicochemical properties remains a challenge. Here, a near-infrared (NIR) light-driven nanosystem with size and charge dual-transformation for deep tumor penetration is developed.

23 July 2018 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
FCFangman Chen
Fangman Chen
FXFangnan Xiao
Fangnan Xiao
WZWeibing Zhang
Weibing Zhang
CLChentao Lin
Chentao Lin
YWYunkun Wu
Yunkun Wu

1 November 2024 in Science Advances
Verified
Journal Article
Open access
ZWZheng Wang
Zheng Wang
YCYinglu Chen
Yinglu Chen
HFHui Fang
Hui Fang
KXKai Xiao
Kai Xiao
ZWZiping Wu
Ziping Wu
DSDan Shao
Dan Shao
Harnessing the immunogenic potential of senescent tumor cells provides an opportunity to remodel tumor microenvironment (TME) and boost antitumor immunity. However, this potential needs to be sophisticatedly wielded to avoid additional immunosuppressive capacity of senescent cells. Our study shows that blocking the JAK2/STAT3 pathway enhances immunogenic efficacy of Aurora kinase inhibitor alisertib (Ali)–induced senescence by reducing immunosuppressive senescence-associated secretory phenotype (SASP) while preserving immunogenic SASP. Hypothesizing that SASP reprogramming with Ali and JAK2 inhibitor ruxolitinib (Rux) will benefit cancer immunotherapy, we create nanoparticulate crystals (Ali-Rux) composed of Ali and Rux with a fully active pharmaceutical ingredient. Immunization with Ali-Rux–orchestrated senescent cells promotes stronger activation of antigen-presenting cells, enhancing antitumor immune surveillance. This approach remodels the TME by increasing CD8 + T cell and NK recruitment and activation while decreasing MDSCs. Combined with PD-L1 blockade, Ali-Rux elicits a durable antitumor immune response, suggesting the TME reshaping approach as a potential cancer immunotherapy.

10 November 2023 in Acta Biomaterialia
Verified
Journal Article
Closed access
XHXuan He
Xuan He
ZCZhimin Chang
Zhimin Chang
FCFangman Chen
Fangman Chen
WZWensheng Zhang
Wensheng Zhang
MSMadi Sun
Madi Sun
CYChao Yang
Chao Yang